LB Pharmaceuticals Added to the Russell 2000® and Russell 3000® Indices
LB Pharmaceuticals Inc (LBRX)
Company Research
Source: GlobeNewswire
NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced the Company has been included in the Russell 2000® Index and the broad-market Russell 3000® Index, effective at the open of U.S. equity markets on December 22, 2025, as part of the 2025 Russell indexes reconstitution. “Inclusion in the Russell 2000 and Russell 3000 indices represents an important milestone following our recent initial public offering,” said Heather Turner, Chief Executive Officer. “We are approaching initiation of key clinical trials of LB-102 in both schizophrenia and bipolar depression, a period of significant momentum for the Company. We expect this recognition to broaden investor awareness of LB Pharmaceuticals.” The annual reconstitution of the Russell US indexes captures the 4,000 largest US stocks as of April 30, ranking them by total market capitalization. Membership in the Russell 3000® Index, which remains in place for
Show less
Read more
Impact Snapshot
Event Time:
LBRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LBRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LBRX alerts
High impacting LB Pharmaceuticals Inc news events
Weekly update
A roundup of the hottest topics
LBRX
News
- LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- LB Pharmaceuticals Announces $100.0 Million Private PlacementGlobeNewswire
- LB Pharmaceuticals initiates Phase 2 trial of LB-102 [Yahoo! Finance]Yahoo! Finance
- LB Pharmaceuticals Initiates Phase 2 ILLUMINATE-1 Trial in Bipolar Depression, Expanding LB-102 Development ProgramGlobeNewswire
- LB Pharmaceuticals Appoints Minako Pazdera, J.D., Ph.D. as General CounselGlobeNewswire
LBRX
Sec Filings
- 2/17/26 - Form SCHEDULE
- 2/10/26 - Form SCHEDULE
- 2/10/26 - Form 4
- LBRX's page on the SEC website